Soleno Therapeutics, Inc. (SLNO) Covered Calls

You can sell covered calls on Soleno Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SLNO (prices last updated Fri 4:16 PM ET):

Soleno Therapeutics, Inc. (SLNO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
51.80 -2.28 49.00 58.99 646K - 2.1
Covered Calls For Soleno Therapeutics, Inc. (SLNO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 50 5.80 53.19 -6.0% -60.8%
Jan 17 50 10.50 48.49 3.1% 17.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.